Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe page revision update shows Revision: v3.3.4, replacing the previous v3.3.3; no study details or eligibility information were changed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2, with no impact to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe Publications section now states that entries are auto-filled from PubMed and may not pertain to the study. It also adds the Revision: v3.3.2 label.SummaryDifference0.1%

- Check63 days agoChange DetectedThe 'Notice Because of a lapse in government funding...' banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedResults First Posted 2025-02-20 are now listed on the study record, and the Publications section has been updated with related articles. Study record dates, including primary completion, have been updated accordingly.SummaryDifference0.4%

- Check106 days agoChange DetectedCore content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.SummaryDifference3%

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.